{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T13:52:15Z","timestamp":1791035535296,"version":"4.1.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,29]],"date-time":"2014-11-29T00:00:00Z","timestamp":1417219200000},"content-version":"vor","delay-in-days":758,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1111\/j.1469-0691.2011.03716.x","type":"journal-article","created":{"date-parts":[[2011,11,7]],"date-time":"2011-11-07T10:11:32Z","timestamp":1320660692000},"page":"1104-1110","source":"Crossref","is-referenced-by-count":61,"title":["Clofazimine in the treatment of multidrug-resistant tuberculosis"],"prefix":"10.1016","volume":"18","author":[{"given":"H.-B.","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.-H.","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.-P.","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2011.03716.x_bib2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1164\/rccm.167.4.603","article-title":"Treatment of tuberculosis","volume":"167","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1469-0691.2011.03716.x_bib3","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1056\/NEJM199309093291108","article-title":"Treatment of multidrug-resistant tuberculosis","volume":"329","author":"Iseman","year":"1993","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"10.1111\/j.1469-0691.2011.03716.x_bib4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1086\/344657","article-title":"Tuberculosis drug resistance. A global threat","volume":"36","author":"Nachega","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03716.x_bib5","first-page":"1176","article-title":"Revised definition of extensively drug-resistant tuberculosis","volume":"55","year":"2006","journal-title":"MMWR"},{"key":"10.1111\/j.1469-0691.2011.03716.x_bib6","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/1791013a0","article-title":"A new series of phenazines (riminocompounds) with high antituberculosis activity","volume":"179","author":"Barry","year":"1957","journal-title":"Nature (London)"},{"key":"10.1111\/j.1469-0691.2011.03716.x_bib7","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/jac\/43.5.615","article-title":"Antimycobacterial activities of riminophenazines","volume":"43","author":"Reddy","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2011.03716.x_bib8","first-page":"752","article-title":"Activities of clofazimine against Mycobacterium tuberculosis in vitro and in vivo","volume":"31","author":"Lu","year":"2008","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"10.1111\/j.1469-0691.2011.03716.x_bib9","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jinf.2005.04.007","article-title":"Efficacy and safety of linezolid in multidrug resistant TB (MDR-TB) - a report of ten cases","volume":"52","author":"von der Lippe","year":"2006","journal-title":"J Infect"},{"key":"10.1111\/j.1469-0691.2011.03716.x_bib10","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/jac\/dkq017","article-title":"Linezolid use for treatment of multidrug-resistant and extensively drug-resistant tuberculosis, New York City, 2000\u201306","volume":"65","author":"Anger","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2011.03716.x_bib11","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/jac\/dki148","article-title":"Linezolid for the treatment of multidrug-resistant tuberculosis","volume":"56","author":"Fortun","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2011.03716.x_bib12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1378\/chest.07-1988","article-title":"Case series report of a linezolid-containing regimen for extensively drug-resistant TB","volume":"134","author":"Condos","year":"2008","journal-title":"Chest"},{"key":"10.1111\/j.1469-0691.2011.03716.x_bib13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1086\/648675","article-title":"Linezolid in the treatment of multidrug-resistant tuberculosis","volume":"50","author":"Schecter","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03716.x_bib14","first-page":"640","article-title":"Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis","volume":"9","author":"Laserson","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1111\/j.1469-0691.2011.03716.x_bib15","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S1472-9792(08)70006-4","volume":"88","year":"2008","journal-title":"Tuberculosis"},{"key":"10.1111\/j.1469-0691.2011.03716.x_bib16","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1056\/NEJMoa0800106","article-title":"Comprehensive treatment of extensively drug-resistant tuberculosis","volume":"359","author":"Mitnick","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1469-0691.2011.03716.x_bib17","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1128\/AAC.43.5.1189","article-title":"Activities of several novel oxazolidinones against Mycobacterium tuberculosis in a murine model","volume":"43","author":"Cynamon","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2011.03716.x_bib18","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/jac\/dkh119","article-title":"Mutant prevention concentration: comparison of fluoroquinolones and linezolid with Mycobacterium tuberculosis","volume":"53","author":"Rodriguez","year":"2004","journal-title":"J Antimicrob Chemother"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14607461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14607461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T01:22:46Z","timestamp":1560907366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14607461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":17,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S1198743X14607461"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03716.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}